Private Equity Physician Deals Fall by Half in 2026 as States Tighten Oversight

STAT Source published: August 17, 2026
Read Full Article →
AI-Generated Summary

Private equity acquisitions of physician practice management (PPM) companies are on track to fall by roughly half in 2026, according to new PitchBook data reported by STAT. Deal volume has collapsed from a 2021 peak of 851 transactions to just 105 in the first half of 2026. STAT attributes much of the slowdown to a wave of new state laws—now on the books in more than a dozen states—that expand government oversight of private equity healthcare deals and corporate practice of medicine (CPOM) arrangements. Reed Smith healthcare partner Paul Pitts called the decline significant, signaling a more cautious, regulation-shaped dealmaking environment for PPM platforms and their sponsors.

Why It Matters

For PE sponsors and multi-site operators, the deal window is narrowing: tighter state CPOM rules and slower PPM dealmaking mean valuations, exit timing, and platform-expansion plans now hinge on regulatory exposure as much as EBITDA. Diligence on state-by-state compliance is becoming a gating factor, not an afterthought.

HGS Take

Use it for: Planning sale or expansion timing in a slower physician-practice deal market. PitchBook data reported by STAT show 105 physician practice management deals in the first half of 2026, down from a peak of 851 in 2021, with the full year on track for about half of 2025’s count.

Watch out for: STAT’s headline says state laws may be curbing deals. The link between new oversight laws and fewer deals is an association, not a proven cause, and market conditions are also cited. The full-year decline is a projection from half-year data.

Try this: List every state you operate in or plan to enter, note whether it has a transaction-notice or corporate-practice law, and add the review time to your deal calendar. The HGS M&A and growth strategy hub collects related deal and regulatory coverage.

private equity healthcare PPM deals corporate practice of medicine physician practice M&A PitchBook data state regulation

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

How much have private equity physician practice deals dropped in 2026?

Private equity deals for physician practice management (PPM) companies are on pace to fall by about half in 2026 versus 2025. PitchBook data show transactions declining from a 2021 high of 851 to just 105 in the first half of 2026.

Why are private equity healthcare deals slowing down?

A major driver is regulation. More than a dozen states have enacted laws expanding oversight of private equity healthcare transactions and corporate practice of medicine (CPOM) structures, adding compliance friction and deal risk. Shifting macroeconomic conditions and heightened scrutiny of practice financials are compounding the slowdown.

What does the PPM slowdown mean for practice owners and sponsors?

Sellers face fewer and more selective buyers, while sponsors must weigh state-level regulatory exposure alongside financial performance. Deal structuring, valuations, and exit timing increasingly depend on how a platform navigates corporate practice of medicine rules in each state it operates.

Keep going
Free tool · ValuationWhat might a practice like this be worth?Turn adjusted EBITDA and a few practice details into a directional enterprise-value range. Educational, ungated, no email.Open the Valuation Calculator →About 3 minutes
Curated by Paul GruensfelderHealthcare growth operator · 13+ years

I keep this library for my own work, then build models and tools when the reading raises a question worth answering.

How I work with operators →
More on this topic